60-day FRN

28050

Federal Register / Vol. 82, No. 117 / Tuesday, June 20, 2017 / Notices

have agreed that NMFS will serve as the
lead agency for this 5-year review.
Section 4(c)(2)(A) of the ESA requires
that we conduct a review of listed
species at least once every five years. On
the basis of such reviews, under section
4(c)(2)(B) we determine whether a
species should be delisted or
reclassified from endangered to
threatened or from threatened to
endangered. Delisting a species must be
supported by the best scientific and
commercial data available and only
considered if such data substantiates
that the species is neither endangered
nor threatened for one or more of the
following reasons: (1) The species is
considered extinct; (2) the species is
considered to be recovered; or (3) the
original data available when the species
was listed, or the interpretation of such
data, were in error (see 50 CFR
424.11(d)). The ESA implementing
regulations at 50 CFR 424.21 require
that we publish a notice in the Federal
Register announcing those species
currently under active review. This
notice announces our active review of
the Gulf of Maine DPS of Atlantic
salmon, currently listed as endangered.
Background information about this
species, including the endangered
listing, is available on the NMFS Greater
Atlantic Regional Fisheries Office Web
site: https://
www.greateratlantic.fisheries.noaa.gov/
protected/atlsalmon/.

sradovich on DSK3GMQ082PROD with NOTICES

Determining if a Species Is Threatened
or Endangered
Section 4(a)(1) of the ESA requires
that we determine whether a species is
endangered or threatened based on one
or more of the five following factors: (1)
The present or threatened destruction,
modification, or curtailment of its
habitat or range; (2) overutilization for
commercial, recreational, scientific, or
educational purposes; (3) disease or
predation; (4) the inadequacy of existing
regulatory mechanisms; or (5) other
natural or manmade factors affecting its
continued existence. Section 4(b) also
requires that our determination be made
on the basis of the best scientific and
commercial data available after taking
into account those efforts, if any, being
made by any State or foreign nation, to
protect such species.
Application of the DPS Policy
In the application of the DPS Policy,
we are responsible for determining
whether species, subspecies, or DPSs of
marine and anadromous species are
threatened or endangered under the
ESA. For Atlantic salmon, we use the
joint U.S. Fish and Wildlife ServiceNMFS DPS policy (61 FR 4722;

VerDate Sep<11>2014

18:01 Jun 19, 2017

Jkt 241001

February 7, 1996) in identifying the
appropriate taxonomic unit for listing
consideration. Under this policy, a DPS
must be discrete from other conspecific
populations, and it must be significant
to its taxon. A group of organisms is
discrete if physical, physiological,
ecological or behavioral factors make it
markedly separate from other
populations of the same taxon. Under
the DPS policy, if a population group is
determined to be discrete, the agency
must then consider whether it is
significant to the taxon to which it
belongs. Considerations in evaluating
the significance of a discrete population
include: (1) Persistence of the discrete
population in an unusual or unique
ecological setting for the taxon; (2)
evidence that the loss of the discrete
population segment would cause a
significant gap in the taxon’s range; (3)
evidence that the discrete population
segment represents the only surviving
natural occurrence of a taxon that may
be more abundant elsewhere outside its
historical geographic range; or (4)
evidence that the discrete population
has marked genetic differences from
other populations of the species.
Public Solicitation of New Information
To ensure that the 5-year review is
complete and based on the best
scientific and commercial data, we are
soliciting new information from the
public, governmental agencies, Tribes,
the scientific community, industry,
environmental entities, and any other
interested parties concerning the status
of the Gulf of Maine DPS. The 5-year
review will consider the best scientific
and commercial data that has become
available since the listing determination
for the Gulf of Maine DPS in June 2009.
Our Northeast Fisheries Science Center
will assist the Greater Atlantic Regional
Fisheries Office in gathering and
analyzing this information. Categories of
requested information include: (1)
Population abundance; (2) population
productivity; (3) changes in species
distribution or population spatial
structure; (4) genetics or other indicators
of diversity; (5) changes in habitat
conditions and associated limiting
factors and threats; (6) conservation
measures that have been implemented
that benefit the species, including
monitoring data demonstrating the
effectiveness of such measures in
addressing identified limiting factors or
threats; (7) data concerning the status
and trends of identified limiting factors
or threats; (8) information that may
affect determinations regarding the
composition of the DPS; (9) other new
information, data, or corrections
including, but not limited to, taxonomic

PO 00000

Frm 00008

Fmt 4703

Sfmt 4703

or nomenclatural changes, identification
of erroneous information in the previous
listing determination, and improved
analytical methods for evaluating
extinction risk.
If you wish to provide information for
this 5-year review, you may submit your
information and materials electronically
via email (see ADDRESSES section). We
request that all information be
accompanied by supporting
documentation such as maps,
bibliographic references, or reprints of
pertinent publications. We also would
appreciate
the submitter’s name, address, and
any association, institution, or business
that the person represents; however,
anonymous submissions will be
accepted.
Authority: 16 U.S.C. 1531 et seq.
Dated: June 15, 2017.
Angela Somma,
Chief, Endangered Species Division, Office
of Protected Resources, National Marine
Fisheries Service.
[FR Doc. 2017–12789 Filed 6–19–17; 8:45 am]
BILLING CODE 3510–22–P

COMMODITY FUTURES TRADING
COMMISSION
Agency Information Collection
Activities: Comment Request—Notice
of Intent To Amend Collection 3038–
0079: Conflicts of Interest Policies and
Procedures by Swap Dealers and
Major Swap Participants
Commodity Futures Trading
Commission.
ACTION: Notice.
AGENCY:

The Commodity Futures
Trading Commission (CFTC or
Commission) is announcing an
opportunity for public comment on a
proposed amendment to the collection
of certain information by the agency.
Under the Paperwork Reduction Act of
1995 (PRA), Federal agencies are
required to publish notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information, and
to allow 60 days for public comment in
response to the notice. This notice
solicits comment on an amendment to
the collection of information under
OMB Control No. 3038–0079 (Conflicts
of Interest Policies and Procedures by
Swap Dealers and Major Swap
Participants).

SUMMARY:

Comments must be submitted on
or before August 21, 2017.

DATES:

E:\FR\FM\20JNN1.SGM

20JNN1

Federal Register / Vol. 82, No. 117 / Tuesday, June 20, 2017 / Notices
You may submit comments,
identified by ‘‘OMB Control No. 3038–
0079; Conflicts of Interest Policies and
Procedures by Swap Dealers and Major
Swap Participants,’’ by any of the
following methods:
• The Commission’s Web site, via its
Comments Online process at http://
comments.cftc.gov/. Follow the
instructions for submitting comments
through the Web site.
• Mail: Christopher Kirkpatrick,
Secretary of the Commission,
Commodity Futures Trading
Commission, Three Lafayette Centre,
1155 21st Street NW., Washington, DC
20581.
• Hand Delivery/Courier: Same as
Mail above.
• Federal eRulemaking Portal: http://
www.regulations.gov/search/index.jsp.
Follow the instructions for submitting
comments through the Portal.
• Please submit your comments using
only one method.
All comments must be submitted in
English, or if not, accompanied by an
English translation. Comments will be
posted as received to http://
www.cftc.gov.

ADDRESSES:

sradovich on DSK3GMQ082PROD with NOTICES

FOR FURTHER INFORMATION CONTACT:

Katherine Driscoll, Associate Chief
Counsel, (202) 418–5544, kdriscoll@
cftc.gov; or Adam Kezsbom, Special
Counsel, (202) 418–5372, akezsbom@
cftc.gov, Division of Swap Dealer and
Intermediary Oversight, Commodity
Futures Trading Commission, 1155 21st
Street NW., Washington, DC 20581.
SUPPLEMENTARY INFORMATION: Under the
PRA, Federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of Information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR 1320.3
and includes agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA, 44 U.S.C.
3506(c)(2)(A), requires Federal agencies
to provide a 60-day notice in the
Federal Register concerning each
proposed collection of information,
including each proposed amendment to
an existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, the CFTC is publishing
notice of the proposed amendment to
the collection of information listed
below. An agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a currently valid OMB
control number.

VerDate Sep<11>2014

18:01 Jun 19, 2017

Jkt 241001

Title: Conflicts of Interest Policies and
Procedures by Swap Dealers and Major
Swap Participants (OMB Control No.
3038–0079). This is a request for an
amendment to a currently approved
information collection.
Abstract: In 2012, the Commission
promulgated Business Conduct
Standards for Swap Dealers and Major
Swap Participants with Counterparties
(External Business Conduct Standards
Final Rulemaking) 1 which include all of
Subpart H of Part 23 of the
Commission’s regulations (EBCS
Rules).2 In the External Business
Conduct Standards Final Rulemaking,
the Commission stated that the
information collections associated with
the EBCS Rules were part of the overall
supervision, compliance and
recordkeeping requirements imposed by
the Commission in certain other
rulemakings including, among others,
the collection of information for rules
on Conflicts of Interest Policies and
Procedures by Swap Dealers and Major
Swap Participants under § 23.605 under
OMB Collection No. 3038–79. While the
collections associated with the EBCS
Rules do overlap with the requirements
in certain other Commission
regulations, the OMB collections
associated with those other Commission
regulations do not accurately reflect the
burdens imposed by the EBCS Rules.
The Commission is proposing to
amend the information collection under
OMB Control No. 3038–0079 to clearly
reflect the paperwork burden imposed
by the EBCS Rules under §§ 23.401–450
and ensure that the paperwork burden
of the EBCS Rules is centrally located
under OMB Control No. 3038–0079. In
addition, the Commission will be
retitling the collection under OMB
Control No. 3038–0079 ‘‘Swap Dealer
and Major Swap Participant Conflicts of
Interest and Business Conduct
Standards with Counterparties’’ to more
accurately reflect its coverage. The
collections of information contained in
1 Business Conduct Standards for Swap Dealers
and Major Swap Participants with Counterparties,
77 FR 9734, Feb. 17, 2012.
2 Subpart H of Part 23 is titled ‘‘Business Conduct
Standards for Swap Dealers and Major Swap
Participants Dealing with Counterparties, Including
Special Entities.’’ Subpart H includes the following
provisions: § 23.400 (Scope); § 23.402 (Definitions);
§ 23.402 (General Provisions); § 23.410 (Prohibition
on fraud, manipulation and other abusive
practices); § 23.430 (Verification of counterparty
eligibility); § 23.431 (Disclosures of material
information); § 23.432 (Clearing disclosures);
§ 23.433 (Communications—fair dealing); § 23.434
(Recommendations to counterparties—institutional
suitability; § 23.440 (Requirements for swap dealers
acting as advisors to Special Entities); § 23.450
(Requirements for swap dealers and major swap
participants acting counterparties to Special
Entities); and § 23.451 (Political contributions by
certain swap dealers).

PO 00000

Frm 00009

Fmt 4703

Sfmt 4703

28051

the EBCS rules are necessary to
implement requirements set forth in the
Dodd-Frank Wall Street Reform and
Consumer Protection Act 3 and for the
protection of investors and market
participants.
With respect to the collection of
information, the CFTC invites
comments on:
• Whether the proposed revision to
the collection of information is
necessary for the proper performance of
the functions of the Commission,
including whether the information will
have a practical use;
• The accuracy of the Commission’s
estimate of the burden of the proposed
revision to the collection of information,
including the validity of the
methodology and assumptions used;
• Ways to enhance the quality,
usefulness, and clarity of the
information to be collected; and
• Ways to minimize the burden of
collection of information on those who
are to respond, including through the
use of appropriate automated electronic,
mechanical, or other technological
collection techniques or other forms of
information technology; e.g., permitting
electronic submission of responses.
All comments must be submitted in
English, or if not, accompanied by an
English translation. Comments will be
posted as received to http://
www.cftc.gov. You should submit only
information that you wish to make
available publicly. If you wish the
Commission to consider information
that you believe is exempt from
disclosure under the Freedom of
Information Act, a petition for
confidential treatment of the exempt
information may be submitted according
to the procedures established in
Regulation 145.9.4
The Commission reserves the right,
but shall have no obligation, to review,
pre-screen, filter, redact, refuse or
remove any or all of your submission
from http://www.cftc.gov that it may
deem to be inappropriate for
publication, such as obscene language.
All submissions that have been redacted
or removed that contain comments on
the merits of the information collection
request will be retained in the public
comment file and will be considered as
required under the Administrative
Procedure Act and other applicable
laws, and may be accessible under the
Freedom of Information Act.
3 See Dodd-Frank Wall Street Reform and
Consumer Protection Act, Public Law 111–203, 124
Stat. 1376 (2010). The text of the Dodd-Frank Act
may be accessed at http://www.cftc.gov/ucm/
groups/public/@swaps/documents/file/hr4173_
enrolledbill.pdf.
4 17 CFR 145.9.

E:\FR\FM\20JNN1.SGM

20JNN1

28052

Federal Register / Vol. 82, No. 117 / Tuesday, June 20, 2017 / Notices

Burden Statement: The respondent
burden for this collection is detailed
below and includes the burden
currently associated with OMB
Collection No. 3038–0079 in connection
with § 23.605 (Conflicts of Interest
Policies and Procedures for Swap
Dealers and Major Swap Participants)
and the EBCS Rules.
The Commission estimates the burden
of this collection of information as
follows:
Respondents/Affected Entities: Swap
Dealers and Major Swap Participants.
Estimated Number of Respondents:
102.
Estimated Average Burden Hours per
Respondent: 2,352.9 hours.
Estimated Total Annual Burden on
Respondents: 240,000 hours.
Frequency of Collection: Ongoing.
Authority: 44 U.S.C. 3501 et seq.
Dated: June 14, 2017.
Robert N. Sidman,
Deputy Secretary of the Commission.
[FR Doc. 2017–12790 Filed 6–19–17; 8:45 am]
BILLING CODE 6351–01–P

DEPARTMENT OF DEFENSE
Office of the Secretary
Notice of Three-Year Extension of
Defense Health Agency Evaluation of
Non-United States Food and Drug
Administration Approved Laboratory
Developed Tests Demonstration
Project
Department of Defense.
Notice of three-year extension of
Defense Health Agency Evaluation of
Non-United States Food and Drug
Administration Approved Laboratory
Developed Tests Demonstration Project.

AGENCY:
ACTION:

This notice is to advise
interested parties of a three-year
extension of a demonstration project
entitled Defense Health Agency (DHA)
Evaluation of Non-United States Food
and Drug Administration (FDA)
Approved Laboratory Developed Tests
(LDTs) Demonstration Project. The
original notice was published on June
18, 2014 (79 FR 34726–34729).
DATES: Effective July 19, 2017.
ADDRESSES: Defense Health Agency
(DHA), Attn: Clinical Support Division,
16401 East Centretech Parkway, Aurora,
CO 80011–9066.
FOR FURTHER INFORMATION CONTACT: Jim
Black, Clinical Support Division,
Defense Health Agency, Telephone
(303) 676–3487.
SUPPLEMENTARY INFORMATION: For
additional information on the DHA

sradovich on DSK3GMQ082PROD with NOTICES

SUMMARY:

VerDate Sep<11>2014

18:01 Jun 19, 2017

Jkt 241001

Evaluation of Non-United States FDA
Approved LDTs Demonstration Project,
please see 79 FR 34726–34729.
According to 32 CFR 199.4(g)(15)(i)(A),
TRICARE may not cost-share medical
devices, including LDTs, that have not
received FDA medical device 510(k)
clearance or premarket approval.
The purpose of this demonstration is
to improve the quality of health care
services for TRICARE beneficiaries.
Under this demonstration, the
Department of Defense reviews nonFDA approved LDTs to determine if
they meet TRICARE’s requirements for
safety and effectiveness, and allows
those that do to be covered as a benefit
under the demonstration. This
demonstration also extends coverage for
prenatal and preconception cystic
fibrosis (CF) carrier screening, when
provided in accordance with the
American College of Obstetricians and
Gynecologists guidelines.
The Department has determined that
continuation of the demonstration
project for an additional three years is
necessary to provide the Secretary with
sufficient information to fully evaluate
the project while continuing to provide
TRICARE beneficiaries and their health
care providers with seamless access to
safe and effective, medically necessary
tests to support health care decisions
and treatment. During the next three
years, the DHA will continue to evaluate
the LDT examination and
recommendation process to assess
feasibility, resource requirements, and
the cost-effectiveness of establishing an
internal safety and efficacy review
process to permit TRICARE cost-sharing
for an ever-expanding pool of non-FDA
approved LDTs, including tests for
cancer risk, diagnosis and treatment,
blood and clotting disorders, a variety of
genetic diseases and syndromes, and
neurological conditions. The results of
the evaluation will provide an
assessment of the potential
improvement of the quality of health
care services for beneficiaries who
would not otherwise have access to
these safe and effective tests and to
support future regulatory revisions
which will enhance the flexibility of the
Military Health System in responding to
emerging technologies. The
demonstration project continues to be
authorized by 10 U.S.C. 1092.
Dated: June 15, 2017.
Aaron Siegel,
Alternate OSD Federal Register Liaison
Officer, Department of Defense.
[FR Doc. 2017–12840 Filed 6–19–17; 8:45 am]

Frm 00010

Fmt 4703

Department of the Navy
Notice of Availability of GovernmentOwned Inventions; Available for
Licensing
Department of the Navy; DoD.
Notice.

AGENCY:
ACTION:

The inventions listed below
are assigned to the United States
Government as represented by the
Secretary of the Navy and are available
for domestic and foreign licensing by
the Department of the Navy.
The following patents are available for
licensing: U.S. Patent No. 9,180,933:
INTEGRATED STERN BULB AND
FLAP//U.S. Patent No. 9,228,805:
CORRUGATED BLAST FREQUENCY
CONTROL PANEL AND METHOD//U.S.
Patent No. 9,230,717: UNIVERSAL
CABLE JACKET REMOVAL TOOL//U.S.
Patent No. 9,238,501: BILGE KEEL
WITH POROUS LEADING EDGE//U.S.
Patent No. 9,306,360: TORSION
ELIMINATING COMPRESSION DEVICE
AND METHOD//U.S. Patent No.
9,307,156: LONGWAVE INFRARED
IMAGING OF A HIGH TEMPERATURE
HIGH INTENSITY LIGHT SOURCE//
U.S. Patent No. 9,340,284: CARGO
SUSPENSION FRAME FOR
AIRCRAFT//U.S. Patent No. 9,365,262:
WIGGLE HULL DESIGN HAVING A
CONCAVE AND CONVEX PLANING
HULL//U.S. Patent No. 9,376,171:
MOORING CLEAT WITH OPEN
DESIGN FOR NON THREAD ENTRY//
U.S. Patent No. 9,376,175: WATER
VESSEL WITH INTEGRATED
BUOYANCY BULB AND STERN
RAMP//U.S. Patent No. 9,381,979:
PORTABLE LIGHTWEIGHT
APPARATUS AND METHOD FOR
TRANSFERRING HEAVY LOADS//U.S.
Patent No. 9,417,155: CALCAREOUS
DEPOSIT WIPE TEST APPARATUS
AND METHOD//U.S. Patent No.
9,421,618: CLAMPING DEVICE FOR
SECURING CABLES TO SUBMERGED
FERROUS HULL SURFACE.//
ADDRESSES: Requests for copies of the
patents cited should be directed to
Office of Counsel, Naval Surface
Warfare Center Carderock Division,
9500 MacArthur Blvd., West Bethesda,
MD 20817–5700.
FOR FURTHER INFORMATION CONTACT: Dr.
Joseph Teter, Director, Technology
Transfer Office, Naval Surface Warfare
Center Carderock Division, Code 0120,
9500 MacArthur Blvd., West Bethesda,
MD 20817–5700, telephone 301–227–
4299.
SUMMARY:

Authority: 35 U.S.C. 207, 37 CFR part 404.

BILLING CODE 5001–06–P

PO 00000

DEPARTMENT OF DEFENSE

Sfmt 4703

E:\FR\FM\20JNN1.SGM

20JNN1